This article aimed to determine modifiable risk factors to prevent massive blood transfusion of blood products (MTBP) during spinal fusion in patients with cerebral palsy.Patient data were queried from a prospectively collected multicenter database. Perioperative MTBP was defined as the administration of allogenic blood products equaling at least half (50%) of the patients’ preoperative blood […]
The post Predictors of massive transfusion of allogenic blood products during posterior spinal fusion in patients with cerebral palsy. first appeared on Physician’s Weekly.
